Godefrooij, Daniel AMangen, Marie-Josee JChan, ElsieO'Brart, David P SImhof, Saskia Mde Wit, G ArdineWisse, Robert P L2018-02-072018-02-072017-10Cost-Effectiveness Analysis of Corneal Collagen Crosslinking for Progressive Keratoconus. 2017, 124 (10):1485-1495 Ophthalmology1549-47132853297410.1016/j.ophtha.2017.04.011http://hdl.handle.net/10029/621340To evaluate the cost effectiveness of corneal collagen crosslinking (CXL) for progressive keratoconus from the healthcare payer's perspective.eninfo:eu-repo/semantics/closedAccessAdultCollagenCorneal StromaCorneal TransplantationCost-Benefit AnalysisCross-Linking ReagentsDisease ProgressionFollow-Up StudiesHealth Care CostsHumansKeratoconusMarkov ChainsMiddle AgedPhotochemotherapyPhotosensitizing AgentsQuality-Adjusted Life YearsRiboflavinUltraviolet RaysVisual AcuityYoung AdultArticleOphthalmology 2017; 124(10):1485-95